While Llovet JM et al demonstrated that a three-gene set comprising glypican-3, LYVE1 (lymphatic vessel endothelial hyaluronan receptor-1) and survivin was able to differentially diagnose HCC from dysplastic nodule tissue with high accuracy [21]. Here, GPC3 is linked to hepatocellular carcinoma.